CASI Pharmaceuticals
CASI
CASI
58 hedge funds and large institutions have $46M invested in CASI Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% less capital invested
Capital invested by funds: $72.3M → $46M (-$26.3M)
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
Holders
58
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$869K | |
| 2 | +$867K | |
| 3 | +$287K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$276K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$235K |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$422K | |
| 3 | -$355K | |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$335K |
| 5 |
JPMorgan Chase & Co
New York
|
-$206K |